Method: Shotgun metagenomic sequencing (CLIA 21D2062464); not cleared or approved by the FDA. Results reflect relative microbial abundance for wellness education purposes. Not intended to diagnose or treat disease and not a substitute for clinical consultation. Microbial associations are based on emerging scientific research and may change over time.
A derived biomarker is a value that is calculated from other directly measured biomarkers rather than being measured directly in the lab.
Key benefits of Helicobacter pylori testing
- H. pylori stomach colonization monitoring
- gastric health and early detection screening
What is Helicobacter pylori?
Helicobacter pylori is a gram-negative bacterium that colonizes the gastric mucosa and is detected through gut microbiome stool sequencing. It is present in approximately half the global population and is a major cause of peptic ulcer disease and gastric cancer risk. Detected by shotgun metagenomic sequencing.
Why is Helicobacter pylori important?
H. pylori is classified as a Group 1 carcinogen (per IARC Monograph Vol. 61), with research primarily focused on gastric outcomes. Many carriers are asymptomatic for years or decades. Detection via microbiome analysis may flag carriers who warrant further clinical evaluation by their care team.
What insights will I get?
Detection of H. pylori in your sample indicates colonization. Discuss your results promptly with your personal clinician to confirm with dedicated clinical testing and determine a clinical course of action. The Superpower care team is available on demand to help you understand your results and prepare questions for your clinician.





.avif)
.avif)

